Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle

Journal of Histochemistry and Cytochemistry

Volumn 57, Issue 1, 2009, Pages 29-39

  Jørgensen, Louise H ^a,b   Petersson, Stine J ^a,b   Sellathurai, Jeeva ^a,b   Andersen, Ditte C ^a,b   Thayssen, Susanne ^b   Sant, Dorte J ^b   Jensen, Charlotte H ^a   Schrøder, Henrik Daa ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Congenital myopathy; Muscular dystrophy; Myogenesis; Satellite cell; Secreted protein acidic and rich in cysteine osteonectin BM 40; Skeletal muscle

Indexed keywords

OSTEONECTIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MUSCULAR DYSTROPHY; MYOPATHY; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SATELLITE CELL; SKELETAL MUSCLE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES; MYOSITIS, INCLUSION BODY; OSTEONECTIN; POLYMYOSITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 58149089974     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.951954     Document Type: Article

References (83)

1. Alexakis C, Partridge T, Bou-Gharios G (2007) Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol 293:C661-669
2. Askanas V, Engel WK (2007) Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr Opin Rheumatol 19:550-559
3. Basu A, Rodeck U, Prendergast GC, Howe CC (1999) Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine. Cell Growth Differ 10:721-728
4. Blazejewski S, Le BB, Boussarie L, Blanc JF, Malaval L, Okubo K, Saric J, et al. (1997) Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts. Am J Pathol 151:651-657
5. Bradshaw AD, Graves DC, Motamed K, Sage EH (2003a) SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA 100: 6045-6050
6. Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Helene SE (2003b) SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120:949-955
7. Bradshaw AD, Reed MJ, Carbon JG, Pinney E, Brekken RA, Sage EH (2001) Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice. Wound Repair Regen 9:522-530
8. Bradshaw AD, Reed MJ, Sage EH (2002) SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem 50:1-10
9. Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049-1054
10. Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, Sage EH (2003) Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest 111:487-495
11. Brekken RA, Sage EH (2000) SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol 19:569-580
12. Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19:816-827
13. Caceres S, Cuellar C, Casar JC, Garrido J, Schaefer L, Kresse H, Brandan E (2000) Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur J Cell Biol 79:173-181
14. Casar JC, Cabello-Verrugio C, Olguin H, Aldunate R, Inestrosa NC, Brandan E (2004a) Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J Cell Sci 117:73-84
15. Casar JC, McKechnie BA, Fallon JR, Young MF, Brandan E (2004b) Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev Biol 268:358-371
16. Charge SB, Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238
17. Chavey C, Boucher J, Monthouel-Kartmann MN, Sage EH, Castan-Laurell I, Valet P, Tartare-Deckert S, et al (2006) Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia. Obesity (Silver Spring) 14:1890-1897
18. Chen YW, Zhao P, Borup R, Hoffman EP (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151:1321-1336
19. Cho WJ, Kim EJ, Lee SJ, Kim HD, Shin HJ, Lim WK (2000) Involvement of SPARC in in vitro differentiation of skeletal myoblasts. Biochem Biophys Res Commun 271:630-634
20. Creuzet S, Lescaudron L, Li Z, Fontaine-Perus J (1998) MyoD, myogenin, and desmin-nls-lacZ transgene emphasize the distinct patterns of satellite cell activation in growth and regeneration. Exp Cell Res 243:241-253
21. Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E (2003) Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology 144:2588-2596
22. Dhawan J, Rando TA (2005) Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 15:666-673
23. Dubois C, Figarella-Branger D, Pastoret C, Rampini C, Karpati G, Rougon G (1994) Expression of NCAM and its polysialylated isoforms during mdx mouse muscle regeneration and in vitro myogenesis. Neuromuscul Disord 4:171-182
24. Engel A, Ozawa E (2004) Dystrophinopathies. In: Engel AG, Franzini-Armstrong C, eds. Myology. New York, McGraw-Hill, 961-1025
25. Fazeli S, Wells DJ, Hobbs C, Walsh FS (1996) Altered secondary myogenesis in transgenic animals expressing the neural cell adhesion molecule under the control of a skeletal muscle alpha-actin , promoter. J Cell Biol 135:241-251
26. Ferre PJ, Liaubet L, Concordet D, SanCristobal M, Uro-Coste E, Tosser-Klopp G, Bonnet A, et al. (2007) Longitudinal analysis of gene expression in porcine skeletal muscle after post-injection local injury. Pharm Res 24:1480-1489
27. Figarella-Branger D, Nedelec J, Pellissier JF, Boucraut J, Bianco N, Rougon G (1990) Expression of various isoforms of neural cell adhesive molecules and their highly polysialylated counterparts in diseased human muscles. J Neurol Sci 98:21-36
28. Foulstone EJ, Huser C, Crown AL, Holly JM, Stewart CE (2004) Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha. Exp Cell Res 294:223-235
29. Gaster M, Beck-Nielsen H, Schroder HD (2002) Regenerating human muscle fibres express GLUT3 protein. Pflugers Arch 445:105-114
30. Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, Anderson JR, Hogan BL, et al. (1998) Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 17:1860-1870
31. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, et al. (2002) Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA 99:15000-15005
32. Henriquez JP, Casar JC, Fuentealba L, Carey DJ, Brandan E (2002) Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation. J Cell Sci 115:2041-2051
33. Heslop L, Morgan JE, Partridge TA (2000) Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 113: 2299-2308
34. Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928
35. Holland PW, Harper SJ, McVey JH, Hogan BL (1987) In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol 105:473-482
36. Horsley V, Pavlath GK (2004) Forming a multinucleated cell: molecules that regulate myoblast fusion. Cells Tissues Organs 176: 67-78
37. Illa I, Leon-Monzon M, Dalakas MC (1992) Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells. Ann Neurol 31:46-52
38. Jejurikar SS, Kuzon WM Jr (2003) Satellite cell depletion in degenerative skeletal muscle. Apoptosis 8:573-578
39. Kitzmann M, Fernandez A (2001) Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci 58:571-579
40. Kuhn C, Mason RJ (1995) Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 147: 1759-1769
41. Kunigal S, Gondi CS, Gujrati M, Lakka SS, Dinh DH, Olivero WC, Rao JS (2006) SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Int J Oncol 29:1349-1357
42. Laing NG (2007) Congenital myopathies. Curr Opin Neurol 20: 583-589
43. Lane TF, Sage EH (1994) The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8:163-173
44. Ledda F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OL (1997a) The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 108:210-214
45. Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, et al. (1997b) Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 3:171-176
46. Lewis MP, Machell JR, Hunt NP, Sinanan AC, Tippett HL (2001) The extracellular matrix of muscle-implications for manipulation of the craniofacial musculature. Eur J Oral Sci 109:209-221
47. Lussier C, Sodek J, Beaulieu JF (2001) Expression of SPARC/osteonectin/ BM40 in the human gut: predominance in the stroma of the remodeling distal intestine. J Cell Biochem 81:463-476
48. Lyons GE, Moore R, Yahara O, Buckingham ME, Walsh FS (1992) Expression of NCAM isoforms during skeletal myogenesis in the mouse embryo. Dev Dyn 194:94-104
49. Maley MA, Davies MJ, Grounds MD (1995) Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp Cell Res 219:169-179
50. Martelly I, Soulet L, Bonnavaud S, Cebrian J, Gautron J, Barritault D (2000) Differential expression of FGF receptors and of myogenic regulatory factors in primary cultures of satellite cells originating from fast (EDL) and slow (Soleus) twitch rat muscles. Cell Mol Biol (Noisy-le-Grand) 46:1239-1248
51. Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493-495
52. Motamed K, Blake DJ, Angello JC, Allen BL, Rapraeger AC, Hauschka SD, Sage EH (2003) Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A. J Cell Biochem 90:408-423
53. Mothe AJ, Brown IR (2001) Differential mRNA expression of the related extracellular matrix glycoproteins SC1 and SPARC in the rat embryonic nervous system and skeletal structure. Brain Res 892:27-41
54. Mourkioti F, Rosenthal N (2005) IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol 26:535-542
55. Musaro A (2005) Growth factor enhancement of muscle regeneration: a central role of IGF-1. Arch Ital Biol 143:243-248
56. Noguchi S, Tsukahara T, Fujita M, Kurokawa R, Tachikawa M, Toda T, Tsujimoto A, et al. (2003) cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 12:595-600
57. Pelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, Nicoletti C, Wannenes F, et al. (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J 21:1393-1402
58. Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, et al. (1996) SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 50:1978-1989
59. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, et al. (2002) A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11:263-272
60. Puolakkainen PA, Bradshaw AD, Brekken RA, Reed MJ, Kyriakides T, Funk SE, Gooden MD, et al. (2005) SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges. J Histochem Cytochem 53:571-581
61. Puolakkainen PA, Brekken RA, Muneer S, Sage EH (2004) Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol Cancer Res 2:215-224
62. Purcell L, Gruia-Gray J, Scanga S, Ringuette M (1993) Developmental anomalies of Xenopus embryos following microinjection of SPARC antibodies. J Exp Zool 265:153-164
63. Rempel SA, Ge S, Gutierrez JA (1999) SPARC: a potential diagnostic marker of invasive meningiomas. Clin Cancer Res 5:237-241
64. Sage H, Vernon RB, Decker J, Funk S, Iruela-Arispe ML (1989a) Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J Histochem Cytochem 37:819-829
65. Sage H, Vernon RB, Funk SE, Everitt EA, Angello J (1989b) SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J Cell Biol 109:341-356
66. Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, Stoppacciaro A, Chiodoni C, et al. (2005) Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J Cell Sci 118:3685-3694
67. Savani RC, Zhou Z, Arguiri E, Wang S, Vu D, Howe CC, DeLisser HM (2000) Bleomycin-induced pulmonary injury in mice deficient in SPARC. Am J Physiol Lung Cell Mol Physiol 279:L743-750
68. Schessl J, Zou Y, Bonnemann CG (2006) Congenital muscular dystrophies and the extracellular matrix. Semin Pediatr Neurol 13:80-89
69. Schultz E, Jaryszak DL, Valliere CR (1985) Response of satellite cells to focal skeletal muscle injury. Muscle Nerve 8:217-222
70. Schwarzbauer JE, Musset-Bilal F, Ryan CS (1994) Extracellular calcium-binding protein SPARC/osteonectin in Caenorhabditis elegans. Methods Enzymol 245:257-270
71. Schwarzbauer JE, Spencer CS (1993) The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility. Mol Biol Cell 4:941-952
72. Seale P, Rudnicki MA (2000) A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev Biol 218:115-124
73. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA (2000) Pax7 is required for the specification of myogenic satellite cells. Cell 102:777-786
74. Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM (1997) Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173:327-334
75. Shi X, Garry DJ (2006) Muscle stem cells in development, regeneration, and disease. Genes Dev 20:1692-1708
76. Socha MJ, Manhiani M, Said N, Imig JD, Motamed K (2007) Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am J Pathol 171:1104-1112
77. Sorokin LM, Maley MA, Moch H, von der Mark H, von der Mark K, Cadalbert L, Karosi S, et al. (2000) Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury. Exp Cell Res 256:500-514
78. Soulet L, Chevet E, Lemaitre G, Blanquaert F, Meddahi A, Barritault D (1994) FGFs and their receptors, in vitro and in vivo studies: new FGF receptor in the brain, FGF-1 in muscle, and the use of functional analogues of low-affinity heparin-binding growth factor receptors in tissue repair. Mol Reprod Dev 39:49-54
79. Stewart JD, Masi TL, Cumming AE, Molnar GM, Wentworth BM, Sampath K, McPherson JM, et al. (2003) Characterization of proliferating human skeletal muscle-derived cells in vitro: differential modulation of myoblast markers by TGF-beta2. J Cell Physiol 196:70-78
80. Strandjord TP, Madtes DK, Weiss DJ, Sage EH (1999) Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis. Am J Physiol 277:L628-635
81. Tartare-Deckert S, Chavey C, Monthouel MN, Gautier N, Van OE (2001) The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem 276:22231-22237
82. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
83. Yan Z, Choi S, Liu X, Zhang M, Schageman JJ, Lee SY, Hart R, et al. (2003) Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem 278:8826-8836